Erratum to: A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson's disease

J Neuroeng Rehabil. 2016 Aug 1;13(1):71. doi: 10.1186/s12984-016-0181-2.

Catarina Godinho^{1

2

3}, Josefa Domingos^{1

3}, Guilherme Cunha⁴, Ana T Santos¹, Ricardo M Fernandes^{1

4}, Daisy Abreu¹, Nilza Gonçalves¹, Helen Matthews⁵, Tom Isaacs⁵, Joy Duffen⁵, Ahmed Al-Jawad⁶, Frank Larsen⁷, Artur Serrano⁷, Peter Weber⁸, Andrea Thoms⁸, Stefan Sollinger⁹, Holm Graessner¹⁰, Walter Maetzler¹¹, Joaquim J Ferreira^{12

13

14}

¹ Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal.
² Instituto Superior de Ciências da Saúde Egas Moniz, Center for Interdisciplinary Research Egas Moniz (CiiEM), Monte de Caparica, Portugal.
³ CNS-Campus Neurológico Sénior, Torres Vedras, Portugal.
⁴ Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
⁵ The Cure Parkinson's Trust, London, UK.
⁶ HSG-IMIT, Villingen-Schwenningen, Germany.
⁷ Norwegian Centre for Telemedicine, Tromso, Norway.
⁸ Hasomed GmbH, Magdeburg, Germany.
⁹ AbilityNet, London, UK.
¹⁰ Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
¹¹ Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Tuebingen, Germany.
¹² Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal. [email protected].
¹³ Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. [email protected].
¹⁴ CNS-Campus Neurológico Sénior, Torres Vedras, Portugal. [email protected].

No abstract available

Publication types